Advertisement

  • Eleven Biotherapeutics Announces Top-Lin...
    From Eleven Biotherapeutics
    Eleven Biotherapeutics announced top-line results from a phase 2 study of its lead drug candidate, EBI-005, in patients with moderate to severe allergic conjunctivitis. T... (Read more)
  • Protein Content in Compounded Bevacizuma...
    From Medscape Ophthalmology
    The protein concentration of bevacizumab prepared by U.S. compounding pharmacies for intravitreal injection shows significant variations, according to New York-based rese... (Read more)
  • Italian Research Provides Preliminary Ev...
    From Medical News Today
    The poster presented during the EuCornea Congress describes the preliminary results of the Phase I segment of the REPARO Study, a randomized, double-masked, placebo contr... (Read more)
  • Johnson & Johnson Vision Care Announces ...
    From Johnson & Johnson Vision Care
    Johnson & Johnson Vision Care announced that Acuvue Oasys brand contact lenses for astigmatism is now the first and only silicone hydrogel toric contact lens with -2.... (Read more)
  • Marco Expands its Management Team
    From Marco
    Marco, a provider of diagnostic equipment for the eye care market, has announced it is expanding its management team. Below are descriptions of new management positions w... (Read more)

Subscribe to EyewireToday.com

e-dition

Mission Statement

New Retina MD is a publication that delivers the latest information on clinical and non-clinical issues that are pertinent to retina specialists in their first 5 to 15 years of practice. Areas of focus include surgical pearls, clinical research endeavors, practice management, medical reimbursement and policy, continuing educational requirements, and financial planning. Each issue provides insight from well-respected voices in appropriate fields of expertise and is designed to fit the needs of physicians in the earlier stages of their careers.